DocumentOpenReport

Add 5 Replacement Contract Circular 4 May 2026 ↓

HealthRef: HP13-2025ARV

Official source

Source domain: health.gov.za

Collected on 25 June 2026

Always confirm details on the official source before acting.

What this means

This document is an annexure (Annexure A) to a contract circular for the supply and delivery of anti-retroviral medicines to South Africa’s Department of Health. It is titled HP13-2025ARV and is marked “CONTRACT CIRCULAR – VERSION 2 – Addendum” for the period 01 December 2025 to 30 November 2028. It lists supplier registration details (including CSD/V-number codes), general pricing rules (delivered price, inclusive of 15% VAT), and a table of awarded therapeutic class items with split percentages, unit delivered prices in ZAR, pack sizes, NSNs, and lead times (≤ 14 calendar days).

What this document offers

Read out of this document by Govermate's AI, in its own words. Each one quotes the line it came from — confirm on the official source before acting.

contracted supply and delivery arrangementOpen

Contract circular (Annexure A) for the supply and delivery of anti-retroviral medicines (HP13-2025ARV) for 01 December 2025 to 30 November 2028

The document lists suppliers and their contract details for the supply and delivery of anti-retroviral medicines to the Department of Health for the period 01 December 2025 to 30 November 2028, including delivered pricing rules (inclusive of 15% VAT) and lead-time requirements.

Who it is for: suppliers/contractors listed in the annexure and involved in contract enquiries and ordering under HP13-2025ARV
How to act on it: Use the contact persons and e-mail addresses indicated hereunder for contract enquiries (not for orders), and ensure that when placing or executing orders the Unit of Measure, National Stock Numbers and prices are carefully matched to the delivered price for the UOM offered.

Facts

Reference

HP13-2025ARV

Amounts

R 55, R 67

Key Takeaways

Document: HP13-2025ARV (Annexure A) SUPPLY AND DELIVERY OF ANTI-RETROVIRAL MEDICINES
Contract circular: VERSION 2 Addendum
Period: 01 December 2025 to 30 November 2028
Pricing rules: delivered basis; prices inclusive of 15% VAT; match UOM/NSN when ordering
Suppliers listed with CSD codes and contact persons (e.g., Viatris Healthcare (Pty) Ltd, Cipla Medpro Manufacturing (Pty) Ltd, Emcure Pharmaceuticals SA (Pty) Ltd, Hetero Drugs SA (Pty) Ltd, Aurobindo Pharma (Pty) Ltd, etc.)
Example awarded items include ABACAVIR/LAMIVUDINE dispersible tablets (e.g., Viatris DUMIVA R55.36; Cipla DIVUDINE R66.70) and DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR combinations (multiple brand names and delivered prices)
Lead-time requirement shown: ≤ MOQ 14 calendar days
Department of Health (South Africa)
National Treasury
Central Supplier Database (CSD)
Aurobindo Pharma (Pty) Ltd
Barrs Pharmaceuticals Industries (Pty) Ltd
Cipla Medpro Manufacturing (Pty) Ltd
Emcure Pharmaceuticals SA (Pty) Ltd
Hetero Drugs SA (Pty) Ltd
Innovata Pharmaceuticals (Pty) Ltd
Macleods Pharmaceuticals SA (Pty) Ltd
Pharma Dynamics (Pty) Ltd
Pharmacare Limited
Sonke Pharmaceuticals (Pty) Ltd
Viatris Healthcare (Pty) Ltd
Mr Munsamy
Mr Erasmus
Mr Maritz
Mr Flear
Mr Johnson
Ms Job
Ms Rajool
Mrs Smith
Mr Ajodapersad

Dates

Closing Date (read from the document by Govermate)

30 November 2028